Current Areas of Controversy in the Treatment of Patients with Newly Diagnosed Acute Promyelocytic Leukemia

This chapter contains sections titled: Introduction Literature search and inclusion Is ara‐C required in induction and/or consolidation in patients with newly diagnosed APL? Can newly diagnosed patients be treated with ATRA and ATO? What is the best treatment for patients with high‐risk APL? Is maintenance therapy needed for all patients with APL? Recommendation References Introduction Literature search and inclusion Is ara‐C required in induction and/or consolidation in patients with newly diagnosed APL? Can newly diagnosed patients be treated with ATRA and ATO? What is the best treatment for patients with high‐risk APL? Is maintenance therapy needed for all patients with APL? Recommendation References